Italy authorises the use of this drug to 250 patients affected by coronary

Tociluzumab, a drug used for arthritis that is not an antiviral but works in chronic inflammation, seems to reduce the risk of patients with Coronavirus having respiratory complications and of being treated in intensive care. This cure is a sign of hope for all of us while we wait for a vaccine [...]
Tociluzumab, a drug used for arthritis that is not an antiviral but works in chronic inflammation, seems to reduce the risk of patients with Coronavirus having respiratory complications and of being treated in intensive care.
This cure is a sign of the strong hope for all of us, while we expect a specific vaccine for Covid-19”, said the head of the Commission for Health and Social Affairs in the Italian Parliament, the Loreficia, Italian media.
After the positive results of the two patients admitted to the Cotugo Hospital in Naples, the use of the Tocilluzomab medicine in 250 other patients with Covid-19” has been attributed to Movement 5 Stars deputy, and at the same time the head of the Social Affairs Commission in the Italian Parliament, in a post on social networks.













